Brigham and Women's Hospital
Boston, MA
Filters
Save & Share
Clear Filters
Diagnosis
Purpose of Trial
Filter and find trials based on their purpose.
Risk Level
Enter this patient's risk level (IPSS-R / IPSS-M).
Not yet accepting
NK Cell Therapy Post-Transplant
Cytokine-induced Memory-like Natural Killer Cell Therapy After Hematopoietic Stem Cell Transplantation for Eradication of Measurable Residual Disease, a Phase I/Ib Clinical Trial
Learn more- Natural Killer Cells (Allogeneic)
- Phase 1
Not yet accepting
MBG453
TIM3 Inhibition With MBG453 for Patients With Lower Risk MDS: an Adaptive Two-Stage Phase II Clinical Trial
Learn more- Monoclonal Antibody
- TIM-3
- Phase 2
Not yet accepting
HEME Hospice - Home Transfusion Program
Supportive Transfusion Program for Patients With Hematologic Malignancies: A Cluster Randomized Trial
Learn more- Randomization
Accepting patients
CMV-MVA Triplex Vaccination
Placebo-Controlled and Randomized Phase 2 Trial of CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors to Enhance CMV-Specific Immunity and Prevent CMV Viremia in Recipients After Hematopoietic Stem Cell Transplant
Learn more- Allogeneic Stem Cell Transplant
- Vaccine
- Placebo
- Randomization
- Phase 2